Doctor Paul Guedeney
Pitie Salpetriere APHP University Hospital, Paris (France)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Respective impact of bleeding and ischemic complications of mortality after percutaneous coronary interventions: substudy from the FRANCE-PCI registry
Event: ESC Congress 2024
Topic: Percutaneous Coronary Intervention (PCI)
Session: The guardians of clotting: exploring antiplatelet strategies
Prevalence, determinants, and impact of significant shunt after percutaneous patent foramen ovale closure
Event: ESC Congress 2024
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Advances in left atrial appendage and patent foramen ovale closure
Venous thrombo-embolic events as the probable cause of arterial ischemic event in patients with patent foramen ovale
Event: ESC Congress 2024
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Advances in left atrial appendage and patent foramen ovale closure
Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors
Event: ESC Congress 2024
Topic: Inflammation and Immunity
Session: Pathophysiology of coronary artery disease: new insights
Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure
Event: ESC Congress 2023
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Young Investigator Awards Session in Thrombosis
Outcomes following patent foramen ovale percutaneous closure according to the delay from last ischemic event
Event: ESC Congress 2022
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Patent foramen ovale closure and left atrial appendage closure
Supraventricular arrhythmia following patent foramen ovale percutaneous closure
Event: ESC Congress 2022
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Patent foramen ovale closure and left atrial appendage closure
Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation
Event: ESC Congress 2022
Topic: Aortic Valve Intervention
Session: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry
Event: ESC Congress 2022
Topic: Cardio-Oncology
Session: Cardio-oncology 1
First clinical experience with the wearable cardiac rhythm long-term monitoring cardioskin device
Event: ESC Congress 2020
Topic: Remote Patient Monitoring and Telehealth
Session: Wearables and the ECG: What Progress Are We Making?
